Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-12

Clinical Trial Update: The Changes of CD8+T Cells Frequency and Function During Antiviral Therapy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates how CD8+ T cell frequency and function change during antiviral therapy in chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B Infection | Phase 4 | Status: UNKNOWN